Literature DB >> 20571616

Constituents of Amoora cucullata with TRAIL resistance-overcoming activity.

Firoj Ahmed1, Kazufumi Toume, Samir K Sadhu, Takashi Ohtsuki, Midori A Arai, Masami Ishibashi.   

Abstract

In search of bioactive natural products for overcoming TRAIL resistance from natural resources, we previously reported a number of active compounds. Bioassay-guided fractionation of mangrove, Amoora cucullata, collected from Sundarbans Mangrove Forest, Bangladesh, led to the isolation of four new compounds (1-4), along with seven known compounds (5-11). Of the isolates, compounds 1, 5, 8, and 9 showed TRAIL resistance-overcoming activity, among which 8 showed the most potent activity and enhanced TRAIL-induced apoptosis in TRAIL-resistant human gastric adenocarcinoma (AGS) cells through the activation of caspase-3/7, enhancing the expression of DR4 and DR5 mRNA in AGS cells. Cell death caused by the combined treatment of 8 and TRAIL was inhibited by human recombinant DR5/Fc and DR4/Fc chimera proteins, indicating that 8 sensitizes TRAIL-resistant AGS cells to TRAIL through the induction of DR4 and DR5.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571616     DOI: 10.1039/c004927a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  4 in total

Review 1.  Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.

Authors:  Li Pan; John L Woodard; David M Lucas; James R Fuchs; A Douglas Kinghorn
Journal:  Nat Prod Rep       Date:  2014-05-02       Impact factor: 13.423

2.  Chromomycins A2 and A3 from marine actinomycetes with TRAIL resistance-overcoming and Wnt signal inhibitory activities.

Authors:  Kazufumi Toume; Kentaro Tsukahara; Hanako Ito; Midori A Arai; Masami Ishibashi
Journal:  Mar Drugs       Date:  2014-06-05       Impact factor: 5.118

3.  Valosin-containing Protein is a Target of 5'-l Fuligocandin B and Enhances TRAIL Resistance in Cancer Cells.

Authors:  Midori A Arai; Shota Taguchi; Kazuhiro Komatsuzaki; Kento Uchiyama; Ayaka Masuda; Mana Sampei; Mamoru Satoh; Sayaka Kado; Masami Ishibashi
Journal:  ChemistryOpen       Date:  2016-10-24       Impact factor: 2.911

4.  The synergistic effects of low dose fluorouracil and TRAIL on TRAIL-resistant human gastric adenocarcinoma AGS cells.

Authors:  Hong Zhu; Min Huang; Daoling Ren; Jianping He; Fen Zhao; Cheng Yi; Ying Huang
Journal:  Biomed Res Int       Date:  2013-11-13       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.